Drop-out of Infertile Couples: a Large Single Center Experience Over 10 Years
NCT06344585 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24773
Last updated 2024-04-24
Summary
Conducted at a single-center, this prospective-retrospective study focused on all couples who initiated their journey at the Fertility Center of Humanitas Research Hospital, Rozzano (Milan), Italy.
The prospective study focused on the couples whose first consultation occurred in 2021. A tailored questionnaire was administered via telephone by staff members to gather insights into the personal reasons for treatment discontinuation among non-returning patients.
Conversely, the retrospective study included all infertile couples initiating treatment between January 2012 and December 2021 at the Fertility Center. Data encompassing personal history and demographic details were extracted from the internal database of Humanitas Fertility Center to assess the factors involved in a treatment discontinuation.
Conditions
Interventions
- OTHER
-
Drop out patients who had their first access in 2021 were additionally asked to answer to a phone -call questionnaire to assess their motivation of discontinuation
A prospective comprehensive analysis of the data contained within patient charts, encompassing personal histories and demographic details, was extracted from the internal database of the Humanitas Fertility Center. This analysis aimed at elucidating the individual reasons for treatment discontinuation after the initial clinical visit throughout the year 2021. Additionally a tailored questionnaire was administered to patients via telephone by a member of Humanitas Fertility Center staff in July 2023. The questionnaire was submitted to the patients via a phone call. The questionnaire comprised nine questions with response limited to 'Yes' and 'No' options for all queries.
Sponsors & Collaborators
-
Istituto Clinico Humanitas
lead OTHER
Principal Investigators
-
Paolo Emanuele Levi Setti · Humanitas Research Hospital IRCCS, Rozzano-Milan
Eligibility
- Min Age
- 18 Years
- Max Age
- 46 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-01-01
- Primary Completion
- 2021-12-31
- Completion
- 2023-07-31
Countries
- Italy
Study Locations
More Related Trials
-
Reproductive Outcome in Assisted Conception Cycles
NCT03846388 ·Status: COMPLETED ·Phase: NA
-
Impact of the Operator Performing Oocyte Retrieval on the Cumulative Live Birth Rate
NCT06933901 ·Status: COMPLETED
-
Intrauterine Insemination Predictor Factors
NCT03836118 ·Status: COMPLETED
-
Azathioprine in Recurrent Implantation Failure
NCT03498703 ·Status: COMPLETED ·Phase: PHASE2
-
Anti-Müllerian Hormone is Not Predictive of Pregnancy in Donor Insemination Cycles in Non-infertile Women
NCT03160872 ·Status: COMPLETED
-
Letrozole vs. Clomiphene Citrate in Patients With Anovulatory Infertility
NCT00610077 ·Status: COMPLETED ·Phase: PHASE3
-
Laparoscopy in Failed IVF
NCT06165484 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Evaluation of Efficacy and Safety of Highly Purified Urofollitropin for Ovulation Induction in Chinese Females
NCT01923194 ·Status: COMPLETED ·Phase: PHASE3
-
Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH) Response to Low Dose Clomiphene Citrate in Normally Menstruating Fertile Women
NCT01340521 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
IUI vs. IVF/ICSI in Women Aged 38-42 Years: a Prospective Randomized Controlled Trial.
NCT01992731 ·Status: UNKNOWN ·Phase: PHASE4
-
Clinical and Live Birth Rates After Following Long Antagonist Protocol Versus Classical Antagonist Protocol
NCT03684421 ·Status: UNKNOWN
-
Patients Perspectives on Discontinuation of Their Fertility Treatment Due to the COVID-19 Pandemic
NCT04396210 ·Status: COMPLETED
-
Use of Corifolitropin Alfa in Oocyte Donors
NCT02213627 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of Fertility Treatments and Fertility Preservation
NCT04602962 ·Status: RECRUITING
-
A Prospective, Multi-centric Observational Study to Determine the Mono-bifollicular Development in Infertile Women Subjected to Ovulation Induction With Follitropin α
NCT01111084 ·Status: COMPLETED
-
ART Cycle Outcomes When Only 1 to 3 Oocytes Are Retrieved
NCT06950476 ·Status: COMPLETED
-
A Prediction Model and Assisted Decision-making System of Fertilization Disorders
NCT05730764 ·Status: UNKNOWN ·Phase: NA
-
Omitting GnRH-antagonist Dose on the Day of Ovulation Trigger
NCT03044756 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Optimizing Ovulation Induction in the Poor Responder
NCT01200537 ·Status: WITHDRAWN ·Phase: NA
-
Norethindrone Impact on Receptiva Outcomes
NCT07134920 ·Status: COMPLETED
-
A New Revolutionary 3-Injection- Protocol in Infertile Women
NCT03877185 ·Status: UNKNOWN
-
Luteal Phase-start Ovarian Stimulation With Corifollitropin Alfa
NCT03555942 ·Status: COMPLETED ·Phase: NA
-
Greening the Humanitas Fertility Center: How to Build a More Sustainable Medical Daily Routine
NCT06239051 ·Status: COMPLETED
-
Cumulative Live Birth After Double Stimulation Protocol Versus Antagonist Protocol for Poor Ovarian Responders
NCT05765968 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effects of Intra-uterine Slow-Release Insemination on Pregnancy Rate in Women Designated for Artificial Insemination
NCT00745563 ·Status: COMPLETED ·Phase: NA